by our College Data Analytics Team
If you’re a veteran, service member, or military-affiliated student looking to study clinical and industrial drug development, you’ve come to the right place. This ranking highlights 6 schools ranked on how well they support veterans pursuing clinical and industrial drug development, using our 2026 methodology.
This ranking is based on the factors that matter most to veteran and military-affiliated students: affordability and veteran financial benefits (including GI Bill and Yellow Ribbon support), academic quality, on-campus veteran resources and support services, veteran-friendly policies, and the size of the veteran student community. So you can compare your options, College Factual reviewed colleges nationwide, drawing primarily on U.S. Department of Education data (IPEDS and College Scorecard).
Want to compare schools head to head? Check out our College Combat to build custom comparisons on the factors you care about most.
Explore the best clinical and industrial drug development colleges for veterans at a specific degree level:
Explore the leading clinical and industrial drug development colleges for veterans below:
Leading the list is University of Washington-Seattle Campus, our #1 clinical and industrial drug development college for veterans. It scores 85.4 out of 100 for serving veteran and military students. Veteran affordability (GI Bill benefits, tuition support) scores 100.0, with a veteran-resources score of 66.7. More about the clinical and industrial drug development program at University of Washington-Seattle Campus
Veteran students seeking a strong clinical and industrial drug development program will find one at Eastern Michigan University, which ranked #2. The school's overall veterans score is 84.3 out of 100. Its affordability for veterans scores 100.0, and veteran resources 100.0. More about the clinical and industrial drug development program at Eastern Michigan University
A rank of #3 makes Temple University one of the top clinical and industrial drug development colleges for veteran students. Temple University scores 76.4 out of 100 for veteran support overall. Veteran affordability (GI Bill benefits, tuition support) scores 100.0, alongside a 66.7 veteran-support score. More about the clinical and industrial drug development program at Temple University
University of California-San Diego came in at #4 on our 2026 list of the best clinical and industrial drug development colleges for veterans. University of California-San Diego scores 75.6 out of 100 for veteran support overall. Veteran affordability (GI Bill benefits, tuition support) scores 100.0, with a veteran-resources score of 66.7. See the full clinical and industrial drug development report for University of California-San Diego
University of Southern California is a great choice for veterans pursuing clinical and industrial drug development, landing the #5 spot this year. It scores 70.6 out of 100 for serving veteran and military students. Its affordability for veterans scores 44.7, with a veteran-resources score of 66.7.
More about the clinical and industrial drug development program at University of Southern California
5
Campbell University landed the #6 spot for veterans pursuing clinical and industrial drug development. The school's overall veterans score is 63.6 out of 100. Veteran affordability (GI Bill benefits, tuition support) scores 67.1, alongside a 66.7 veteran-support score. More about the clinical and industrial drug development program at Campbell University
*These averages are for the top 25 ranked colleges only.
We measure this ranking on the factors that matter most to veteran and military-affiliated students studying clinical and industrial drug development: affordability and veteran financial benefits (GI Bill, Yellow Ribbon), academic quality, on-campus veteran resources and support services, veteran-friendly policies, and the size of the veteran student community.
These rankings are produced by College Factual, 2026 edition.
References
More about our data sources and methodologies.
